Analyst Price Targets — AGL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 9, 2026 12:47 pm | George Hill | Deutsche Bank | $33.00 | $19.84 | TheFly | Agilon Health price target adjusted to $33 from $2 at Deutsche Bank |
| April 8, 2026 1:02 pm | — | Evercore ISI | $16.00 | $18.47 | TheFly | Agilon Health price target adjusted to $16 at Evercore ISI after reverse split |
| October 7, 2025 10:51 am | — | Wells Fargo | $37.50 | $28.00 | TheFly | Agilon Health price target lowered to $1.50 from $5 at Wells Fargo |
| August 15, 2025 3:08 pm | Jack Slevin | Jefferies | $27.50 | $27.38 | TheFly | Agilon Health price target lowered to $1.10 from $2.40 at Jefferies |
| October 29, 2024 4:08 pm | Daniel Grosslight | Citigroup | $62.50 | $63.00 | StreetInsider | Citi Downgrades agilon health Inc (AGL) to Sell |
| October 2, 2024 3:29 pm | Adam Ron | Bank of America Securities | $75.00 | $88.38 | TheFly | Agilon Health downgraded to Underperform from Buy at BofA |
| August 8, 2024 4:08 pm | George Hill | Deutsche Bank | $100.00 | $140.00 | StreetInsider | agilon health Inc (AGL) PT Lowered to $4 at Deutsche Bank |
| May 29, 2024 4:17 pm | Michael Ha | Robert W. Baird | $150.00 | $144.00 | TheFly | Agilon Health initiated with a Neutral at Baird |
| May 24, 2024 5:53 am | Jailendra Singh | Truist Financial | $162.50 | $141.25 | StreetInsider | agilon health Inc (AGL) PT Raised to $6.50 at Truist Securities |
| July 26, 2022 7:49 pm | David MacDonald | Truist Financial | $825.00 | $628.25 | Pulse 2.0 | Agilon Health (AGL) Stock: $33 Target And Buy Rating |
Latest News for AGL
Agilon Health (NYSE: AGL - Get Free Report) and iSpecimen (NASDAQ: ISPC - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings. Risk and Volatility Agilon Health has a beta
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the first quarter 2026 after market close on Wednesday, May 6, 2026 and host a conference call at 4:30 p.m. ET to discuss the results. The conference call can be accessed by dialing (833) 461-5787 for…
PHILADELPHIA, March 31, 2026 (GLOBE NEWSWIRE) -- Stockholder rights firm Kaskela Law announces that it is investigating Agilon Health, Inc. (NYSE: AGL) (“Agilon”) on behalf of the company's long-term investors. Click here for additional information: https://kaskelalaw.com/case/agilon-health/ Recently a securities fraud complaint was filed against Agilon on behalf of certain investors who purchased shares of…
Shares of Agilon Health, Inc. (NYSE: AGL - Get Free Report) have received a consensus rating of "Hold" from the sixteen analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and three have given a buy recommendation to
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AGL.
U.S. House Trading
No House trades found for AGL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.